Isabel Haro

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Rheumatology and therapy

International journal of molecular sciences

PloS one

Pharmaceutics

Consejo Superior de Investigaciones Científicas

University of Barcelona-CSIC (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Consejo Superior de Investigaciones Científicas Nov 25 2004

Spain

Research Scientist

Consejo Superior de Investigaciones Científicas Mar 01 1990 - Nov 24 2004

Spain

Staff Scientist

Consejo Superior de Investigaciones Científicas Jan 08 1988 - Dec 31 1989

Spain

Postdoctoral fellow :: Peptides

Royal Free Hospital Jul 01 1989 - Oct 01 1989

United Kingdom

Postdoctoral fellow

Consejo Superior de Investigaciones Cientificas

Spain

Predoctoral fellow :: Department of Peptides

Hoechst Ibérica S.A.

Spain

Research Assistant

University of Barcelona

Spain

Assistant professor :: Faculty of Chemistry. Biochemistry Department

Centro de Investigación CROS

Spain

Research Assistant

Education History

University of Barcelona-CSIC

Spain

PHD :: Department of Peptides CID-CSIC

University of Barcelona

Spain

MSC :: Faculty of Chemitry

University of Barcelona

Spain

BSC :: Faculty of Chemistry

Publications

Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy 11 (3) (2024)
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy 11 (3) (2024)
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy 11 (3) (2024)
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy 11 (3) (2024)
Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J Gómara, Ana Belén Azuaga, Juan Camilo Sarmiento, Rosa M Morlà, Virginia Ruiz-Esquide, Laura Macias-Muñoz, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D Cañete, Jordi Yague, Josep Maria Auge, José A Gómez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmartí
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study. Rheumatology and therapy (2024)
Lorena Rodríguez-Martínez, Cristina García-Moreno, Eva Perez-Pampin, María José Gómara, Juan Camilo Sarmiento, Yolanda Lopez-Golán, José A Gómez-Puerta, Antonio Mera-Varela, Carmen Conde, Raimon Sanmartí, Isabel Haro, Antonio González
Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression. Arthritis research & therapy 25 (1) (2023)
Elena Sánchez-Lopez, María José Gómara, Isabel Haro
Atorvastatin-loaded peptide amphiphiles against corneal neovascularization. Nanomedicine (London, England) (2023)
Ruth Galindo, Elena Sánchez-Lopez, María José Gómara, Marta Espina, Miren Etchetto, Amanda Cano, Isabel Haro, Antonio Camins Espuny, María Luisa García
Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation. Pharmaceutics 14 (2) (2022)
Isabel Haro, Raimon Sanmartí, María José Gómara
Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis. International journal of molecular sciences 23 (24) (2022)
Isabel Haro, Raimon Sanmartí, María José Gómara
Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis. International journal of molecular sciences 23 (24) (2022)
Isabel Haro, Raimon Sanmartí, María José Gómara
Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis. International journal of molecular sciences 23 (24) (2022)
Isabel Haro, Raimon Sanmartí, María José Gómara
Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis. International journal of molecular sciences 23 (24) (2022)
María José Gómara, Ramon Pons, Carolina Herrera, Paul Ziprin, Isabel Haro
Peptide Amphiphilic-Based Supramolecular Structures with Anti-HIV-1 Activity. Bioconjugate chemistry 32 (9) (2021)
Cristina García-Moreno, María José Gómara, Raul Castellanos-Moreira, Raimon Sanmartí, Isabel Haro
Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients. International journal of molecular sciences 22 (24) (2021)
Elena Sánchez-Lopez, Anna Paús, Ignacio Pérez-Pomeda, Ana-Cristina Calpena-Campmany, Isabel Haro, María José Gómara
Lipid Vesicles Loaded with an HIV-1 Fusion Inhibitor Peptide as a Potential Microbicide. Pharmaceutics 12 (6) (2020)
María José Gómara, Yolanda Perez, Patricia Gomez-Gutierrez, Carolina Herrera, Paul Ziprin, Javier P Martinez, Andreas Meyerhans, Juan J Perez, Isabel Haro
Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide. Scientific reports 10 (1) (2020)
Raul Castellanos-Moreira, Sebastian Cruz Rodríguez-García, José A Gómez-Puerta, Virginia Ruiz-Esquide, Oscar Camacho, Julio Ramírez, Andrea Cuervo, Rosa M Morlà, Juan D Cañete, Isabel Haro, Raimon Sanmartí
Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype? The Journal of rheumatology 47 (5) (2019)
María J Gómara, Javier Rodríguez, María J Bleda, Juan P Salvador, Raimon Sanmartí, Isabel Haro
Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays. Clinical chemistry and laboratory medicine 56 (2) (2019)
Cristina García-Moreno, María José Gómara, María José Bleda, Raimon Sanmartí, Isabel Haro
Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis. PloS one 14 (5) (2019)
Carolina Beltran-Pavez, Carolina B Ferreira, Alberto Merino-Mansilla, Amanda Fabra García, Maria Casadella, Marc Noguera-Julian, Roger Paredes, Àlex Olvera, Isabel Haro, Christian Brander, Felipe Garcia, Jose M Gatell, Eloisa Yuste, Victor Sanchez-Merino
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant. PloS one 13 (12) (2018)
Martha Ariza-Sáenz, Marta Espina, Ana Calpena, María J Gómara, Ignacio Pérez-Pomeda, Isabel Haro, María Luisa García
Design, Characterization, and Biopharmaceutical Behavior of Nanoparticles Loaded with an HIV-1 Fusion Inhibitor Peptide. Molecular pharmaceutics 15 (11) (2018)
Yolanda Pérez, Maria José Gómara, Eloísa Yuste, Patricia Gómez-Gutierrez, Juan Jesús Pérez, Isabel Haro
Structural Study of a New HIV-1 Entry Inhibitor and Interaction with the HIV-1 Fusion Peptide in Dodecylphosphocholine Micelles. Chemistry (Weinheim an der Bergstrasse, Germany) 23 (48) (2017)

Isabel Haro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Isabel Haro